4DMEDICAL Ltd (AU:4DX) — Market Cap & Net Worth
Market Cap & Net Worth: 4DMEDICAL Ltd (4DX)
4DMEDICAL Ltd (AU:4DX) has a market capitalization of $1.84 Billion (AU$2.60 Billion) as of June 21, 2026. Listed on the AU stock exchange, this Australia-based company holds position #6590 globally and #151 in its home market, demonstrating a 25.07% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 4DMEDICAL Ltd's stock price AU$4.54 by its total outstanding shares 573784088 (573.78 Million). Review how much debt does 4DMEDICAL Ltd carry to assess the company's total debt and financial obligations.
4DMEDICAL Ltd Market Cap History: 2020 to 2026
4DMEDICAL Ltd's market capitalization history from 2020 to 2026. Data shows growth from $986.55 Million to $1.84 Billion (19.58% CAGR).
Index Memberships
4DMEDICAL Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P/ASX All Technology
AXTX
|
$108.73 Billion | 1.70% | #12 of 53 |
Weight: 4DMEDICAL Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
4DMEDICAL Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 4DMEDICAL Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
272.58x
4DMEDICAL Ltd's market cap is 272.58 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $986.55 Million | $216.98K | -$21.42 Million | 4546.79x | N/A |
| 2021 | $548.08 Million | $1.05 Million | -$24.59 Million | 519.86x | N/A |
| 2021 | $548.08 Million | $216.98K | -$21.42 Million | 2525.99x | N/A |
| 2022 | $170.52 Million | $718.58K | -$31.46 Million | 237.29x | N/A |
| 2022 | $170.52 Million | $1.05 Million | -$24.59 Million | 161.73x | N/A |
| 2023 | $290.28 Million | $3.75 Million | -$35.98 Million | 77.32x | N/A |
| 2023 | $290.28 Million | $718.58K | -$31.46 Million | 403.97x | N/A |
| 2024 | $194.87 Million | $5.85 Million | -$30.07 Million | 33.29x | N/A |
| 2024 | $194.87 Million | $3.75 Million | -$35.98 Million | 51.91x | N/A |
| 2025 | $1.60 Billion | $5.85 Million | -$30.07 Million | 272.58x | N/A |
Competitor Companies of 4DX by Market Capitalization
Companies near 4DMEDICAL Ltd in the global market cap rankings as of June 21, 2026.
Key companies related to 4DMEDICAL Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
4DMEDICAL Ltd Historical Marketcap From 2020 to 2026
Between 2020 and today, 4DMEDICAL Ltd's market cap moved from $986.55 Million to $ 1.84 Billion, with a yearly change of 19.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$1.84 Billion | +15.52% |
| 2025 | AU$1.60 Billion | +718.75% |
| 2024 | AU$194.87 Million | -32.87% |
| 2023 | AU$290.28 Million | +70.24% |
| 2022 | AU$170.52 Million | -68.89% |
| 2021 | AU$548.08 Million | -44.44% |
| 2020 | AU$986.55 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 20th, 2026 the market cap of 4DMEDICAL Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.84 Billion USD |
| MoneyControl | $1.84 Billion USD |
| MarketWatch | $1.84 Billion USD |
| marketcap.company | $1.84 Billion USD |
| Reuters | $1.84 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About 4DMEDICAL Ltd
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function im… Read more